Kovid 19 Haberleri


        
 
Haber:
Etiketler:
Yazarın adı:
Yazarın soyadı:


13 Şubat 2022, Pazar, 16:02 Haber Kaynağı: Çeşitli Haber Siteleri
Koronavirüs aşılarının adet döngüsüne etkisi incelenecek
Avrupa İlaç Ajansı (EMA), Pfizer/BioNTech ve Moderna aşılarından sonra bazı kadınların menstrüel (adet) döngülerinde değişiklikler yaşadığını bildirmesi üzerine inceleme başlatma kararı aldı. 
https://www.gercekgundem.com/saglik/326238/koronavirus-asilarinin-adet-dongusune-etkisi-incelenecek

13 Şubat 2022, Pazar, 14:03 Haber Kaynağı: Çeşitli Haber Siteleri
Tayvan'dan Omicron'a özel aşı
Tayvan’da Academia Sinica Araştırma Enstitüsü, Omicron mutasyonuna özgü yeni bir aşı geliştirdiklerini duyurdu. Aşının testlerdeki ilk sonuçlarının olumlu olduğu bilgisi paylaşıldı.
https://www.cnnturk.com/dunya/tayvandan-omicrona-ozel-asi

13 Şubat 2022, Pazar, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
EARLY RELEASE: Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
This report describes how vaccine effectiveness against COVID-19-associated emergency department/urgent care visits and hospitalizations was higher after the third dose but decreased with time.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=529420

13 Şubat 2022, Pazar, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
EARLY RELEASE: Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022
This report describes how local and systemic reactions and myocarditis are less frequent after a homologous COVID-19 booster dose.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=529035

13 Şubat 2022, Pazar, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022
This report describes genomic surveillance sequencing of COVID-19 variants by jurisdiction.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=525250

13 Şubat 2022, Pazar, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccination Coverage and Vaccine Confidence by Sexual Orientation and Gender Identity - United States, August 29-October 30, 2021
This report describes COVID-19 vaccination coverage by sexual orientation and gender identity.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=510954

13 Şubat 2022, Pazar, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022
This report describes how COVID-19 vaccinations and booster doses were associated with lower chances of ICU admission for hospitalized SARS-CoV-2 infected adults during Omicron predominance.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=514039

13 Şubat 2022, Pazar, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022
This report describes COVID-19 incidence and hospitalization rates during Omicron predominance in January 2022.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=508967

13 Şubat 2022, Pazar, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
This report describes COVID-19 vaccine effectiveness time frames among people who received their first and second doses of the vaccine series, and effectiveness of third vaccine doses during both Delta- and Omicron-predominant periods.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=492999

13 Şubat 2022, Pazar, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021
This report describes COVID-19 incidence rate ratios for unvaccinated versus fully vaccinated persons with and without booster vaccine doses during the emergence of the Omicron variant.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=492998